Brigida S

Department of Pharmacology, Sree Balaji Medical College and Hospital, Chrompet, Chennai, India


  • Research   
    Cost Analysis of Different Brands of New in Class Anti-Anginal drugs Marketed in India
    Author(s): Soujania Singh G*, Arul Amutha Elizabeth and Brigida S

    Angina pectoris, is the foremost manifestation of Ischemic Heart Disease, bring about by transient interlude of Myocardial Ischemia that are due to disproportion in the myocardial oxygen supply-demand interconnection. The treatment aims to improve Myocardial Oxygen supply and workload reduction. Few recently introduced drugs for angina are Ranolazine and Ivabradine which is been used along with other medicines nowadays. This article aims to bring out the cost-effectiveness of varying doses of these drugs by different pharmaceutical companies. Prices of various brands of newer anti-anginal drugs of various strengths marketed by the pharmaceutical companies were collected from the current anthology of apothecary. The difference betwixt the top to bottom cost of the equivalent medication mass produced by different pharmaceutical firms and proportion variation in rate for ten tablets was .. Read More»

    Abstract HTML PDF